Main useThis Rybelsus oral-tablet record is for type 2 diabetes.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- リベルサス錠3mg／7mg／14mg
- Brand
- Rybelsus
- Generic name
- Semaglutide
- Japanese generic name
- セマグルチド
- Chinese name
- 司美格鲁肽
- Marketing authorization holder
- ノボ ノルディスク ファーマ株式会社
- Strengths
- 3 mg / 7 mg / 14 mg
- Dosage form
- oral tablet
- Therapeutic area
- मेटाबॉलिक
- Regulatory status
- Rx
- Label updated
- 2026-05-22
- TOKYO MEDI verified
- 2026-09-23
Other Japanese products with the same ingredient
オゼンピック皮下注2mg · ウゴービ皮下注（複数規格）
This page uses a representative Japanese product as the reference entry; other products or dosage forms may exist for the same ingredient.
आधिकारिक स्रोत
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.